Evaluation of Potential Thrombin Inhibitors from the White Mangrove (Laguncularia racemosa (L.) C.F. Gaertn.)
Authors:
- Caroline Fabri Bittencourt RodriguesCRCaroline Fabri Bittencourt Rodrigues
- Henrique Hessel GaetaHGHenrique Hessel Gaeta
- Mariana Novo BelchorMBMariana Novo Belchor
- Marcelo José Pena FerreiraMFMarcelo José Pena Ferreira
- Marcus Vinícius Terashima PinhoMPMarcus Vinícius Terashima Pinho
- Daniela De Oliveira ToyamaDTDaniela De Oliveira Toyama
- Marcos Hikari ToyamaMTMarcos Hikari Toyama
Open Access
- 21 July 2015
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 13 (7) , 4505-4519
Abstract
The aim of this work was to verify the effects of methanol (MeOH) and hydroalcoholic (HA) extracts and their respective partition phases obtained from white mangrove (Laguncularia racemosa (L.) C.F. Gaertn.) leaves on human thrombin activity. Among the extracts and phases tested, only the ethyl acetate and butanolic partitions significantly inhibited human thrombin activity and the coagulation of plasma in the presence of this enzyme. Chromatographic analyses of the thrombin samples incubated with these phases revealed that different compounds were able to interact with thrombin. The butanolic phase of the MeOH extract had the most potent inhibitory effects, reducing enzymatic activity and thrombin-induced plasma coagulation. Two glycosylated flavonoids in this partition were identified as the most potent inhibitors of human thrombin activity, namely quercetin-3-O-arabinoside (QAra) and quercetin-3-O-rhamnoside (Qn). Chromatographic analyses of thrombin samples incubated with these flavonoids demonstrated the chemical modification of this enzyme, suggesting that the MeOH extract contained other compounds that both induced structural changes in thrombin and diminished its activity. In this article, we show that despite the near absence of the medical use of mangrove compounds, this plant contains natural compounds with potential therapeutic applications.Keywords
This publication has 26 references indexed in Scilit:
- Recent progress in anticoagulant therapy: oral direct inhibitors of thrombin and factor XaJournal of Thrombosis and Haemostasis, 2011
- Condensed Tannins from Mangrove Species Kandelia candel and Rhizophora mangle and Their Antioxidant ActivityMolecules, 2010
- Biodiversidade: fonte potencial para a descoberta de fármacosQuímica Nova, 2009
- Flavonoids inhibit the amidolytic activity of human thrombinBiochimie, 2006
- Emerging anticoagulants for the treatment of venous thromboembolismThrombosis and Haemostasis, 2006
- Warfarin and Other Coumarin Derivatives: Pharmacokinetics, Pharmacodynamics, and Drug InteractionsSeminars in Vascular Medicine, 2003
- The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart diseaseClinica Chimica Acta, 1995
- Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activationCell, 1991
- Monocyte Chemotaxis: Stimulation by Specific Exosite Region in ThrombinScience, 1983
- Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: Structure-activity relationshipsInflammation Research, 1982